Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hemet, CA
NPI
1003801390
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
750 E Latham Ave, Suite 1
Hemet, CA, 92543
Phone (951) 766-6696
Medicare paid, 2024
$17K
153 services
Medicare patients, 2024
63
Average age 68
Drug cost, 2024
$371K
1,150 prescriptions
Company payments, 2025
$77.07
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kazem Seyed was code 99215 (office e&m - established), 137 times for 54 patients. In total Kazem Seyed billed 153 services in 4 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 137 | 54 | $110.33 | $15K |
| 99205 Office E&M - New | Office | 13 | 13 | $151.55 | $1,970 |
By year: 2022 $22K for 176 services; 2023 $24K for 180 services; 2024 $17K for 153 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kazem Seyed prescribed most often to Medicare patients was Levothyroxine Sodium, with 191 prescriptions and refills. In total Kazem Seyed wrote 1,150 Medicare prescriptions that cost $371K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 191 | 409 | 46 | $1,924 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 83 | 114 | 13 | $45K |
| Ozempic Semaglutide | 60 | 106 | 15 | $94K |
| Methimazole Generic | 59 | 112 | 13 | $408 |
| Farxiga Dapagliflozin Propanediol | 52 | 94 | 14 | $48K |
| Jardiance Empagliflozin | 47 | 70 | Under 11 | $37K |
| Metformin Hcl Generic | 43 | 107 | 14 | $372 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 37 | 75 | 12 | $6,440 |
| Januvia Sitagliptin Phosphate | 32 | 42 | Under 11 | $21K |
| Atorvastatin Calcium Generic | 31 | 67 | 11 | $106 |
| Testosterone Cypionate Generic | 31 | 37 | Under 11 | $688 |
| Calcitriol Generic | 30 | 50 | Under 11 | $1,231 |
| Glipizide Generic | 26 | 63 | Under 11 | $107 |
| Hydrocortisone Generic | 19 | 26 | Under 11 | $536 |
| Steglatro Ertugliflozin Pidolate | 18 | 44 | Under 11 | $16K |
Brand drugs: 563 claims; generic drugs: 510 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kazem Seyed $77.07 ($77.07 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $77.07.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 4 | $77.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.